APA

Bindraban A. N., Rolvink J., Berger F. A., van den Bemt P. M. L. A., Kuijper A. F. M., van der Hoeven R. T. M., Mantel-Teeuwisse A. K. & Becker M. L. (20190129). Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs. : International journal of clinical pharmacy.

Chicago

Bindraban Anita N, Rolvink José, Berger Florine A, van den Bemt Patricia M L A, Kuijper Aaf F M, van der Hoeven Ruud T M, Mantel-Teeuwisse Aukje K and Becker Matthijs L. 20190129. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs. : International journal of clinical pharmacy.

Harvard

Bindraban A. N., Rolvink J., Berger F. A., van den Bemt P. M. L. A., Kuijper A. F. M., van der Hoeven R. T. M., Mantel-Teeuwisse A. K. and Becker M. L. (20190129). Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs. : International journal of clinical pharmacy.

MLA

Bindraban Anita N, Rolvink José, Berger Florine A, van den Bemt Patricia M L A, Kuijper Aaf F M, van der Hoeven Ruud T M, Mantel-Teeuwisse Aukje K and Becker Matthijs L. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs. : International journal of clinical pharmacy. 20190129.